Tech Company Financing Transactions

Tercica Funding Round

Rho Ventures, Care Capital and MedImmune Ventures invested in a $44 million Series B funding round for Tercica. This VC investment round was announced by the company on 7/17/2003.

Transaction Overview

Company Name
Tercica
Announced On
7/17/2003
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series B
Investors

Rho Ventures (Lead Investor) (Mark Leschly)

Care Capital

MedImmune Ventures (Wayne Hockmeyer)

MPM Capital

Prospect Venture Partners

Proceeds Purpose
The proceeds from the financing will be used to complete commercial manufacturing scale-up, conduct additional clinical studies with IGF-1, including late-stage trials in diabetes, and build a field specialist force to serve the pediatric endocrinology community.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2000 Sierra Point Parkway 400
Brisbane, CA 94005
USA
Phone
(650) 624-4900
Website
www.tercica.com
Email Address
[email protected]
Overview
Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders.
Profile
Tercica LinkedIn Company Profile
Social Media
Tercica Company Twitter Account
Company News
Tercica News
Facebook
Tercica on Facebook
YouTube
Tercica on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Scarlett
  John Scarlett LinkedIn Profile  John Scarlett Twitter Account  John Scarlett News  John Scarlett on Facebook
Chief Financial Officer
Ajay Bansal
  Ajay Bansal LinkedIn Profile  Ajay Bansal Twitter Account  Ajay Bansal News  Ajay Bansal on Facebook
Chief Medical Officer
Thorsten Stein
  Thorsten Stein LinkedIn Profile  Thorsten Stein Twitter Account  Thorsten Stein News  Thorsten Stein on Facebook
Chief Operating Officer
Richard King
  Richard King LinkedIn Profile  Richard King Twitter Account  Richard King News  Richard King on Facebook
Chief Technical Officer
Ross Clark
  Ross Clark LinkedIn Profile  Ross Clark Twitter Account  Ross Clark News  Ross Clark on Facebook
Executive Vice President
Stephen Rosenfield
  Stephen Rosenfield LinkedIn Profile  Stephen Rosenfield Twitter Account  Stephen Rosenfield News  Stephen Rosenfield on Facebook
Vice President
Sandra Blethen
  Sandra Blethen LinkedIn Profile  Sandra Blethen Twitter Account  Sandra Blethen News  Sandra Blethen on Facebook
Vice President
George Bright
  George Bright LinkedIn Profile  George Bright Twitter Account  George Bright News  George Bright on Facebook
VP - Finance
Susan Wong
  Susan Wong LinkedIn Profile  Susan Wong Twitter Account  Susan Wong News  Susan Wong on Facebook
VP - Human Resources
William Yates
  William Yates LinkedIn Profile  William Yates Twitter Account  William Yates News  William Yates on Facebook
VP - Marketing
Russell Cox
  Russell Cox LinkedIn Profile  Russell Cox Twitter Account  Russell Cox News  Russell Cox on Facebook
VP - Operations
Andrew Grethlein
  Andrew Grethlein LinkedIn Profile  Andrew Grethlein Twitter Account  Andrew Grethlein News  Andrew Grethlein on Facebook
VP - Sales
Gordon Treadway
  Gordon Treadway LinkedIn Profile  Gordon Treadway Twitter Account  Gordon Treadway News  Gordon Treadway on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/16/2003: FlexLight Networks venture capital transaction
Next: 7/17/2003: Compellent Technologies venture capital transaction

 

Share this article

 

News on VC Transactions

We report on funding rounds that are announced publicly. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.